Talk:Bi-specific T-cell engager

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

How are they made

Could also have a History of when/why proposed. - Rod57 (talk) 13:39, 19 February 2016 (UTC)[reply]

What type of T cells do they activate

- Rod57 (talk) 13:39, 19 February 2016 (UTC)[reply]

Should we separate approved drugs from investigational, or just group by target antigen

Should we separate approved drugs from investigational, or just group by target antigen ? I propose grouping by target antigen, since clinical approval status changes, and soon there will be multiple drug candidates per target antigen. - Rod57 (talk) 11:34, 28 January 2022 (UTC)[reply]

Talk:Bi-specific T-cell engager

How are they made

What type of T cells do they activate

Should we separate approved drugs from investigational, or just group by target antigen

Navigation menu

Search